HBM Healthcare Investments Reports 6.5% Stake in ALX Oncology Holdings Inc. (ALXO)

On May 15, 2026, HBM Healthcare Investments (Cayman) Ltd. filed a Schedule 13G/A regarding its holdings in ALX Oncology Holdings Inc. (ALXO). The filing indicates that as of March 31, 2026, the reporting person beneficially owns 8,590,692 shares of Common Stock, representing approximately 6.5% of the company's outstanding shares. This reflects an increase from a previously reported 0.0% ownership position, marking a significant entry or restoration of a reportable stake. The calculation is based on 131,608,278 shares of Common Stock outstanding as reported in the issuer's Annual Report on Form 10-K. HBM Healthcare Investments (Cayman) Ltd. is a Cayman Islands-based entity, and voting and investment power over these shares is exercised by its Board of Directors, which includes Jean-Marc LeSieur and several others. The filing was made under Rule 13d-1(c), certifying that the shares were not acquired for the purpose of changing or influencing the control of the issuer.